DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+10.83%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.99B
AUM Growth
+$2.99B
(-2.3%)
Cap. Flow
-$245M
Cap. Flow
% of AUM
-8.2%
Top 10 Holdings %
Top 10 Hldgs %
35.72%
Holding
154
New
30
Increased
26
Reduced
34
Closed
30
Top Buys
| 1 |
Viatris
VTRS
|
$58.4M |
| 2 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$56.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$38.2M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$35.8M |
| 5 |
Galapagos
GLPG
|
$33.1M |
Top Sells
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$446M |
| 2 |
AbbVie
ABBV
|
$89.8M |
| 3 |
Adverum Biotechnologies
ADVM
|
$85.8M |
| 4 |
BLUE
bluebird bio
BLUE
|
$51.3M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$27.7M |
Sector Composition
| 1 | Healthcare | 71.13% |
| 2 | Financials | 3.44% |
| 3 | Technology | 0.52% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $426M | 14.19% | 12,259,875 -532,814 | -4% | -$18.5M |
|
|
AVDL
2
Avadel Pharmaceuticals
AVDL
$1.43B
| $86.3M | 2.88% | 4,072,809 | – | – |
|
|
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
| $82.5M | 2.75% | 5,773,050 +700,000 | +14% | +$10M |
|
|
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
| $68.7M | 2.29% | 9,529,361 -2,305,234 | -19% | -$16.6M |
|
|
DYAX
5
DELISTED
DYAX CORPORATION
DYAX
| $65.8M | 2.19% | 2,483,507 +1,352,093 | +120% | +$35.8M |
|
6
Vanda Pharmaceuticals
VNDA
$279M
| $60.7M | 2.02% | 4,784,157 +650,000 | +16% | +$8.25M |
|
|
7
Viatris
VTRS
$12.3B
| $59.1M | 1.97% | 871,000 +861,000 | +8,610% | +$58.4M |
|
8
GSK
GSK
$79.9B
| $57.3M | 1.91% | 1,376,722 +503,537 | +58% | +$21M |
|
|
ALPN
9
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $56.5M | 1.88% | +3,732,412 | New | +$56.5M |
|
|
BLUE
10
DELISTED
bluebird bio
BLUE
| $55M | 1.83% | 326,783 -304,526 | -48% | -$51.3M |
|
|
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
| $54.8M | 1.82% | 648,501 +135,701 | +26% | +$11.5M |
|
12
DaVita
DVA
$9.85B
| $50.5M | 1.68% | 636,000 -94,000 | -13% | -$7.47M |
|
|
AET
13
DELISTED
Aetna Inc
AET
| $47.1M | 1.57% | 369,739 +85,439 | +30% | +$10.9M |
|
|
UAM
14
DELISTED
Universal American Corp
UAM
| $44.6M | 1.49% | 4,409,703 -776,445 | -15% | -$7.86M |
|
|
GWPH
15
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $44.5M | 1.48% | 361,953 -1,747 | -0.5% | -$215K |
|
16
Charles River Laboratories
CRL
$8.04B
| $43M | 1.43% | 611,436 +321,986 | +111% | +$22.6M |
|
17
eHealth
EHTH
$118M
| $41.4M | 1.38% | 3,264,588 | – | – |
|
|
AERI
18
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $39M | 1.3% | 2,211,644 +1,605,526 | +265% | +$28.3M |
|
|
ATRS
19
DELISTED
Antares Pharma, Inc.
ATRS
| $38.3M | 1.27% | 18,389,789 +6,311,471 | +52% | +$13.1M |
|
|
20
Teva Pharmaceuticals
TEVA
$21.1B
| $38.2M | 1.27% | +646,000 | New | +$38.2M |
|
|
ONCE
21
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $38M | 1.27% | 631,192 | – | – |
|
|
ELGX
22
DELISTED
Endologix Inc
ELGX
| $37.6M | 1.25% | 2,449,897 +100,546 | +4% | +$1.54M |
|
23
Larimar Therapeutics
LRMR
$310M
| $34.9M | 1.16% | 1,007,614 -42,564 | -4% | -$1.47M |
|
|
ADPT
24
DELISTED
Adeptus Health Inc.
ADPT
| $34.6M | 1.15% | 364,000 +165,400 | +83% | +$15.7M |
|
|
25
Galapagos
GLPG
$2.07B
| $33.1M | 1.1% | +642,608 | New | +$33.1M |
|